158 related articles for article (PubMed ID: 24439964)
1. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning.
Boyle JM; Craciunescu O; Steffey B; Cai J; Chino J
Brachytherapy; 2014; 13(4):332-6. PubMed ID: 24439964
[TBL] [Abstract][Full Text] [Related]
2. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position.
Iatì G; Pontoriero A; Mondello S; Brogna A; Di Pasquale A; Ielo I; Potami A; Messina G; De Renzis C; Pergolizzi S
Brachytherapy; 2014; 13(6):568-71. PubMed ID: 24986362
[TBL] [Abstract][Full Text] [Related]
4. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
[TBL] [Abstract][Full Text] [Related]
5. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium.
Kumar NP; Kumar A; Jayaprakash PG; Raghukumar P; James FV
J Cancer Res Ther; 2018; 14(6):1191-1195. PubMed ID: 30488828
[TBL] [Abstract][Full Text] [Related]
7. Should the organs at risk be contoured in vaginal cuff brachytherapy?
Holloway CL; Macklin EA; Cormack RA; Viswanathan AN
Brachytherapy; 2011; 10(4):313-7. PubMed ID: 21193355
[TBL] [Abstract][Full Text] [Related]
8. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.
Park SJ; Chung M; Demanes DJ; Banerjee R; Steinberg M; Kamrava M
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):840-6. PubMed ID: 24138921
[TBL] [Abstract][Full Text] [Related]
11. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
12. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
Kim RY; Shen S; Duan J
Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
[TBL] [Abstract][Full Text] [Related]
13. Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition.
Sabater S; Andres I; Sevillano M; Berenguer R; Machin-Hamalainen S; Arenas M
Brachytherapy; 2014; 13(4):343-51. PubMed ID: 24388615
[TBL] [Abstract][Full Text] [Related]
14. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
15. Three-dimension anatomy-based planning optimization for high dose rate vaginal vault brachytherapy.
Bahadur YA; Hassouna AH; Constantinescu CT; Naga AF; Ghasal NM; Elsayed ME
Saudi Med J; 2012 Jun; 33(6):640-7. PubMed ID: 22729119
[TBL] [Abstract][Full Text] [Related]
16. Image-guided brachytherapy for cervical cancer: analysis of D2 cc hot spot in three-dimensional and anatomic factors affecting D2 cc hot spot in organs at risk.
Kim RY; Dragovic AF; Whitley AC; Shen S
Brachytherapy; 2014; 13(2):203-9. PubMed ID: 23953809
[TBL] [Abstract][Full Text] [Related]
17. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
[TBL] [Abstract][Full Text] [Related]
18. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
[TBL] [Abstract][Full Text] [Related]
19. Evaluating adjacent organ radiation doses from postoperative intracavitary vaginal vault brachytherapy for endometrial cancer.
Caon J; Holloway C; Dubash R; Yuen C; Aquino-Parsons C
Brachytherapy; 2014; 13(1):94-9. PubMed ID: 24269147
[TBL] [Abstract][Full Text] [Related]
20. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]